United States Non-Invasive Prenatal Testing (NIPT) Market Size, Share, Emerging Trends, Current Analysis, Growth, Demand, Opportunity, and Forecast 2022 – 2030

Amid the COVID-19 crisis, the United States market for non-invasive prenatal testing (NIPT) estimated at US$ 788 million in the year 2021, is expected to reach a revised market size of US$ 2,557 Million by 2030, growing at a CAGR of 13.9% over the period 2021 - 2030.

The Prominent Factors that are Expected to Contribute to the Growth of the United States Non-Invasive Prenatal Testing Market During the Forecast Period:

increase in incidences of chromosomal aneuploidies among fetus
progress of advanced non-invasive prenatal testing products
rising adoption regarding non-invasive prenatal testing
growing focus on reimbursement for non-invasive prenatal testing
increasing preference for non-invasive techniques over invasive methods
ACOG guidelines recommend NIPT for all pregnancies regardless of risk

After conducting thorough research on the historical and current growth parameters, the growth prospects of the United States non-invasive prenatal testing (NIPT) market are obtained with maximum precision.

This new 2022 market report provides a holistic analysis of the entire United States non-invasive prenatal testing market. The report offers the most uptodate industry data on the actual market situation and future outlook for the United States non-invasive prenatal testing market. The report also provides uptodate historical market size data for the period 2018 2021 and an illustrative forecast to 2030 covering key market aspects like market value and volume for non-invasive prenatal testing in the United States.

The report also includes the latest insights on comparative test analysis by companies. The following points are covered in the comparative test analysis: technology, fetal fraction, starting week, twin, sex chromosome aneuploidy, gender, deletion/duplication, triploidy, turnaround time, egg donor, accuracy, and many more.

Additionally, this up-to-date report describes the latest features reimbursement pattern and offers a clear view of the regulatory framework of the United States noninvasive prenatal testing market.

The report also tracks and analyses competitive developments, including collaboration deals, mergers & acquisitions, venture capital investment, distribution, exclusive and licensing agreements, and partnerships deals.

The report also covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market.

The report will serve as a source for a 360-degree analysis, thoroughly integrating different models.

This Newest and Comprehensive the United States Non-Invasive Prenatal Testing Market Research Report 2022 Delivers:

Comprehensive Research Methodology of the United States Non-Invasive Prenatal Testing Market
The report includes a Detailed and Extensive Market Overview with Key Analyst Insights
Insights about market determinants that are stimulating the United States Non-Invasive Prenatal Testing Market
To Analyse the Historical Growth in the Market Size of the United States NonInvasive Prenatal Testing Market from 2018 to 2021
To Estimate and Forecast the Market Size of the United States NonInvasive Prenatal Testing Market from 2022 to 2030 and Growth Rate until 2030
The Market Size of the United States Average Risk NonInvasive Prenatal Testing Market with Eight Years Forecast
The Market Size of the United States High-Risk NonInvasive Prenatal Testing Market with Eight Years Forecast
Evaluates the Number of NIPT Tests Performed in the United States with Eight Years Forecast
Studies the United States Number of Average Risk NIPT Tests Performed with Eight Years Forecast
Examines the United States Number of High-Risk NIPT Tests Performed with Eight Years Forecast
Assessment of Market Potential and Opportunities for this Innovation-Driven United States NonInvasive Prenatal Testing Market with Eight Years Forecast
Insights into the United States Average and High-Risk Potential NIPT Tests Market with Eight Years Forecast
Meticulously Assesses the Overall United States Potential NonInvasive Prenatal Testing (NIPT) Volume and Future Trends
Analyses of the United States Average and High-Risk Potential Number of Tests Performed with Eight Years Forecast
Detailed Insights into the Regulatory Framework of the United States NonInvasive Prenatal Testing Market
Features Reimbursement Patterns of the United States NonInvasive Prenatal Testing Market
Tracks Competitive Developments, Approaches, Recent Industry Developments, Mergers & Acquisitions, Collaboration Deals, Partnership Deals, Distribution, Exclusive, and Licensing Agreement
Extensive Profiles and Recent Developments of 12 Market Players.


The Key Market Players for the United States NonInvasive Prenatal Testing Market are Listed Below:

Illumina, Inc.
Natera, Inc.
Quest Diagnostics
Myriad Genetics, Inc.
Centogene
GenPath
PerkinElmer
Yourgene Health
Invitae Corporation
Agilent Technologies
Ariosa Diagnostics (Roche)
Laboratory Corporation of America Holdings

Key Questions Answered in this Report:

What is the current scenario of the united states noninvasive prenatal testing market?
What is the total market size and forecast (until 2030) for the united states noninvasive prenatal testing market?
How big is the united states NIPT tests market?
Which is the best non-invasive prenatal test?
How has the potential market performed so far and how will it perform in the coming years?
How many NIPT tests are being performed in the united states during 2018 2030?
What is the market size of the average risk NIPT tests in the united states?
What is the market size of the high-risk NIPT tests in the united states?
What are the key marketed NIPT tests available in the united states?
What are the major drivers of the united states noninvasive prenatal testing market?
What are the major inhibitors of the united states noninvasive prenatal testing market?
What is the reimbursement pattern in the united states noninvasive prenatal testing market?
What is the regulatory framework in the united states noninvasive prenatal testing market?
What are the major deals and agreement happenings in the united states noninvasive prenatal testing market?
What companies offer NIPT tests in the united states?
Who are the top market players? What are their happenings, current developments, and scenarios?
How is the market predicted to develop in the future?

1. Executive Summary

2. United States Actual NonInvasive Prenatal Testing Volume (Number of Tests Performed) and Forecast (2018 - 2030)
2.1 Average Risk Actual NIPT Test Volume (Number of Tests Performed) and Forecast
2.2 High-Risk Actual NIPT Test Volume (Number of Tests Performed) and Forecast

3. United States Potential NonInvasive Prenatal Testing Volume (Number of Tests Performed) and Forecast (2018 - 2030)
3.1 Average Risk Potential NIPT Test Volume (Number of Tests Performed) and Forecast
3.2 High-Risk Potential NIPT Test Volume (Number of Tests Performed) and Forecast

4. United States Actual NonInvasive Prenatal Testing Market Size and Forecast (2018 - 2030)
4.1 Average Risk Actual NIPT Test Market Size and Forecast
4.2 High-Risk Actual NIPT Test Market Size and Forecast

5. United States Potential NonInvasive Prenatal Testing Market Size and Forecast (2018 - 2030)
5.1 Average Risk Potential NIPT Test Market Size and Forecast
5.2 High-Risk Potential NIPT Test Market Size and Forecast

6. United States NonInvasive Prenatal Testing Market Growth Drivers and Challenges
6.1 Key Market Growth Drivers
6.2 Key Market Challenges

7. NonInvasive Prenatal Testing Comparative Analysis

8. Reimbursement Environment of the United States Non-Invasive Prenatal Testing

9. Regulation Framework of the United States Non-Invasive Prenatal Testing

10. Major Deals and Agreements in the NonInvasive Prenatal Testing Market
10.1 Collaboration Deals
10.2 Venture Capital Investment
10.3 Mergers and Acquisitions
10.4 Exclusive Agreement
10.5 Licensing Agreement
10.6 Distribution Agreement
10.7 Partnership Deals

11. Key Companies Analysis
11.1 Laboratory Corporation of America Holdings
11.1.1 Business Overview
11.1.2 Product Outlook
11.1.3 Key Developments
11.2 Yourgene Health
11.2.1 Business Overview
11.2.2 Product Outlook
11.2.3 Key Developments
11.3 Ariosa Diagnostics (Roche)
11.3.1 Business Overview
11.3.2 Product Outlook
11.3.3 Key Developments
11.4 Illumina,Inc.
11.4.1 Business Overview
11.4.2 Product Outlook
11.4.3 Key Developments
11.5 Natera,Inc.
11.5.1 Business Overview
11.5.2 Product Outlook
11.5.3 Key Developments
11.6 Quest Diagnostics
11.6.1 Business Overview
11.6.2 Product Outlook
11.6.3 Key Developments
11.7 Myriad Genetics,Inc.
11.7.1 Business Overview
11.7.2 Product Outlook
11.7.3 Key Developments
11.8 Centogene
11.8.1 Business Overview
11.8.2 Product Outlook
11.8.3 Key Developments
11.9 Invitae Corporation
11.9.1 Business Overview
11.9.2 Product Outlook
11.9.3 Key Developments
11.10 GenPath
11.10.1 Business Overview
11.10.2 Product Outlook
11.10.3 Key Developments
11.11 PerkinElmer
11.11.1 Business Overview
11.11.2 Product Outlook
11.11.3 Key Developments
11.12 Agilent Technologies
11.12.1 Business Overview
11.12.2 Product Outlook
11.12.3 Key Developments

List Of Tables

Table 61: Maternal Age at Delivery and Risk of Down Syndrome
Table 71: NonInvasive Prenatal Testing Comparative Tests Analysis
Table 101: Collaboration Deals in the NonInvasive Prenatal Testing Market
Table 102: Venture Capital Investment in the NonInvasive Prenatal Testing Market
Table 103: Merger & Acquisition in the NonInvasive Prenatal Testing Market
Table 104: Exclusive Agreement in the NonInvasive Prenatal Testing Market
Table 105: Licensing Agreement in the NonInvasive Prenatal Testing Market
Table 106: Distribution Agreement in the NonInvasive Prenatal Testing Market
Table 107: Partnership Deals in the NonInvasive Prenatal Testing Market

List Of Figures

Figure 21: United States Actual NIPT Test Volume (Thousand),2018 2021
Figure 22: United States Actual NIPT Test Volume Forecast (Thousand),2022 2030
Figure 23: United States Average Risk Actual NIPT Test Volume (Thousand),2018 2021
Figure 24: United States Average Risk Actual NIPT Test Volume Forecast (Thousand),2022 2030
Figure 25: United States High-Risk Actual NIPT Test Volume (Thousand),2018 2021
Figure 26: United States High-Risk Actual NIPT Test Volume Forecast (Thousand),2022 2030
Figure 31: United States Potential NIPT Test Volume (Thousand),2018 2021
Figure 32: United States Potential NIPT Test Volume Forecast (Thousand),2022 2030
Figure 33: United States Average Risk Potential NIPT Test Volume (Thousand),2018 2021
Figure 34: United States Average Risk Potential NIPT Test Volume Forecast (Thousand),2022 2030
Figure 35: United States High-Risk Potential NIPT Test Volume (Thousand),2018 2021
Figure 36: United States High-Risk Potential NIPT Test Volume Forecast (Thousand),2022 2030
Figure 41: United States Actual NIPT Test Market Size (Million US$),2018 2021
Figure 42: United States Actual NIPT Test Market Size Forecast (Million US$),2022 2030
Figure 43: United States Average Risk Actual NIPT Test Market Size (Million US$),2018 2021
Figure 44: United States Average Risk Actual NIPT Test Market Size Forecast (Million US$),2022 2030
Figure 45: United States High-Risk Actual NIPT Test Market Size (Million US$),2018 2021
Figure 46: United States High-Risk Actual NIPT Test Market Size Forecast (Million US$),2022 2030
Figure 51: United States Potential NIPT Test Market Size (Million US$),2018 2021
Figure 52: United States Potential NIPT Test Market Size Forecast (Million US$),2022 2030
Figure 53: United States Average Risk Potential NIPT Test Market Size (Million US$),2018 2021
Figure 54: United States Average Risk Potential NIPT Test Market Size Forecast (Million US$),2022 2030
Figure 55: United States High-Risk Potential NIPT Test Market Size (Million US$),2018 2021
Figure 56: United States High-Risk Potential NIPT Test Market Size Forecast (Million US$),2022 2030

Fill The Form For Sample Request

Full Name*

Business Email *

E-mail

Country *

Select Country Albania Algeria Afghanistan Angola Argentina Armenia Aruba Australia Austria Azerbaijan Andorra Anguilla Bahrain Bangladesh Barbados Belarus Belgium Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Bosnia Cambodia Cameroon Central African Republic Chad Chile China Colombia Comoros Congo (Brazzaville) Cook Islands Costa Rica Cote d Ivoire Croatia Cuba Cyprus Czech Republic Cayman Islands Denmark Djibouti Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Gibraltar Greece Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Herzegovina Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kuwait Korea Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Lithuania Luxembourg Liechtenstein Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Middle East & North Africa (MENA) Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria North Korea Norway Oman Pakistan Palau Palestinian Territories Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Palestine Qatar Romania Russia Rwanda Samoa Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Korea Spain Sri Lanka Saint Kitts and Nevis Saint Vincent and the Grenadines Sudan Suriname Swaziland Sweden Switzerland Syria Scotland San Marino Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States of America Uruguay Uzbekistan Uraguay Vanuatu Venezuela Vietnam Virgin Islands Yemen Zambia Zimbabwe Canada Grenada Cape Verde Belize Curacao Republic of Srpska Antigua and Barbuda Saint Lucia Falkland Islands Faroe Islands Federated States of Micronesia Guadeloupe Martinique Montserrat Niue

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available